DeutschNewstral
Article
jdsupra.com on 2017-03-23 20:10
Novartis Secures FDA Approval for Breast Cancer Drug Kisqali
Related news
Celcuity secures FDA 'breakthrough therapy designation' for breast cancer drugStar Tribune- BFDA Grants Full Approval to Gilead Breast Cancer Drugbarrons.com
UCLA breast cancer research leads to Ibrance drug FDA approvaldailybruin.com
FDA expedites approval of two new breast cancer treatmentsnewatlas.com
Pfizer breast cancer drug gets early FDA approvalTimesDaily.com
Pfizer breast cancer drug gets accelerated FDA approvalThe Salt Lake Tribune
Genentech pulls breast cancer drug after FDA questions accelerated approvalbizjournals.com- Maryland biotech seeks FDA approval for breast cancer treatmentbizjournals.com
- MacroGenics seeks FDA approval for breast cancer treatmentbizjournals.com
- FDA OKs new Novartis drug for type of advanced breast cancerStar Tribune
23andMe gets FDA approval to report breast cancer risk without a doctorSan Jose Mercury News- MMylan shares rise as FDA advisors recommend breast-cancer drug approvalmarketwatch.com
23andMe gets FDA approval for at-home breast cancer risk testwtnh.com- MacroGenics strikes commercialization deal ahead of potential FDA approval for breast cancer treatmentbizjournals.com
- FGilead secures FDA approval for remdesivirft.com
- SFDA alerts: Rare cancer with breast implantsstmarynow.com
FDA says Novartis withheld data problem before drug approvalSeattle Times